Organogenesis Holdings Inc. (ORGO) stock
ORGONasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.85+0.04 (+5.13%)
Close on Nov 18, 2026Market cap $109.78MP/E –Yield –
Organogenesis pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Organogenesis's pe ratio was 112.2× on Jul 31, 2026, against 75.5× a year earlier. Over the last 5 years it ranged from 5.8× to 906.8×, with a median of 38.8×.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Jul 31, 2026 | 112.2× | −542.0 |
| 2025 | Dec 31, 2025 | 654.1× | +578.6 |
| 2024 | Jul 31, 2024 | 75.5× | +34.6 |
| 2023 | Dec 29, 2023 | 40.9× | +34.8 |
| 2022 | Dec 30, 2022 | 6.1× | −14.4 |
| 2021 | Dec 31, 2021 | 20.5× | −153.5 |
| 2017 | Oct 31, 2017 | 174.0× | – |
See a number that looks wrong?